TENX 8-K: SEC filing
Tenax Therapeutics
Filed with the SEC on · accession 0001193125-26-448517
TENX filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -9.9% by the first close after the filing.
Summary of the filing
Tenax Therapeutics issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
Key details
How TENX stock reacted
Close before
$1.81
Nov 4, 2026
First close after
-9.94%
$1.63
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for TENX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TENX?
Click hereFrequently asked questions
What did TENX file with the SEC on Nov 5, 2026?
TENX filed a 8-K (SEC filing). Tenax Therapeutics issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did TENX stock react to this filing?
TENX closed at $1.81 before the filing and $1.63 on Nov 5, 2026 (-9.94%).
Other TENX SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingOct 8, 2026
- 8-K · SEC filingSep 9, 2026
- 8-K · Fda approvalAug 10, 2026
- 8-K · SEC filingJul 31, 2026
- 10-Q · SEC filingJul 31, 2026
- 8-K · Fda approvalJul 2, 2026
- 8-K · Material agreementJun 30, 2026
- 8-K · Executive departureJun 29, 2026
- 8-K · Board changeJun 4, 2026
Get alerts when TENX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days